BAKER BROS. ADVISORS LP 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 4:10 pm Purchase | 2026-04-30 | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 33,012,138 10.800% | 5,486,498 (+19.93%) | Filing |
| 2024-11-14 4:11 pm Purchase | 2024-09-30 | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 27,525,640 9.300% | 4,615,887 (+20.15%) | Filing |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 22,909,753 7.900% | 22,909,753 (New Position) | Filing |